Safety and Efficacy of the Investigational Agent Orteronel (TAK-700) Without Prednisone in Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC) Patients with Rising Prostate-Specific Antigen (PSA): Updated Results from a Phase 2 Study

M. Hussain, P. Corn, D. Michaelson,H. Hammers,J. Alumkal,C. Ryan, J. Bruce,S. Moran,S. Lee, N. Borgstein, I Webb,P. Mortimer, D. George

UROLOGY(2012)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要